Skip to main content
Sebi ‘censures’ AstraZeneca for unfair trade practise in 2014 delisting plans - Livemint 07-Jun-2020
Sebi ‘censures’ AstraZeneca for unfair trade practise in 2014 delisting plans - Livemint
The order found that the pharma company, its promoters and Elliot group which held 15.52% in the company through six foreign institutional investor (FII) sub-accounts had a ‘private arrangement’ to sail through the delisting process
More...